Form 1 CARE Feedback survey

OMB No.: 0925-0766
Expiration Date: 04/30/2023
Public reporting burden for this collection of information is estimated to average 2 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and
maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for
reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0766). Do not return the completed form to this address.

2022 NCI SBIR Development Center Program with FDA
CARE – Connecting Awardees with Regulatory Experts
* 1. Company Information
Company Name
Contact Person
Title/Role
Email

* 2. Please indicate the extent to which you agree with the following. Participation in the
CARE Program helped our team…
Strongly Agree
Learn and/or confirm the FDA Center
(CBER, CDER, CDRH) or Office that will
regulate our technology
Begin developing the regulatory strategy
for our technology
Plan the next regulatory step(s) for our
technology
Clarify and/or confirm the appropriate
regulatory path for our technology
Gain a better understanding of the process
to contact FDA for a meeting request
Find information on FDA’s website related
to a particular regulatory topic
Understand how to contact an FDA office
that provides free resource assistance to
industry (i.e., MATTB, SBIA, or DICE)

Agree

Disagree

Strongly
Disagree

* 3. Please indicate the extent to which you agree with the following. Following the CARE
Program, our team plans to…

Strongly Agree

Agree

Disagree

Strongly
Disagree

Contact an FDA office via phone or email
that provides free resource assistance to
industry (i.e., MATTB, SBIA, or DICE)
Watch an FDA webinar(s) on a particular
regulatory topic
Read an FDA guidance(s) on a particular
regulatory topic
Access an FDA website to learn more on a
particular regulatory topic
Submit a meeting request to FDA to discuss
regulatory strategy (e.g., INTERACT
meeting, pre-IND meeting, pre-submission
meeting, etc.)

* 4. Please indicate the extent to which you agree with the following. Our team…

Strongly Agree

Agree

Disagree

Found the CARE Program useful
Found the NCI SBIR FDA resources website
useful https://sbir.cancer.gov/resources/fdaresources
Received information from the CARE
Program that will affect our future
SBIR/STTR specific aims
Would recommend the CARE Program to
other companies

5. We welcome any additional feedback or comments you wish to provide.

Strongly
Disagree